EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Integrin-αvβ6 targeted peptide-toxin therapy in a novel αvβ6-expressing immunocompetent model of pancreatic cancer

Nicholas F Brown, Elizabeth R Murray, Lauren C Cutmore, Philip Howard, Luke Masterson, Francesca Zammarchi, John A Hartley, Patrick H van Berkel, John F Marshall

Pancreatology · 2024

DOI: 10.1016/j.pan.2024.02.013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pancreatology, 2024. Verfasst von Nicholas F Brown und 8 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, EC1M 6BQ, …. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Research UK London Research Institute, Pancreatic Cancer Research Fund, Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsCarcinoma, Pancreatic DuctalHumansMiceAnimalsCell Line, TumorIntegrinsPeptidesAntigens, Neoplasm

Substanzen

integrin alphavbeta6IntegrinsPeptidesAntigens, Neoplasm

Autor:innen und Institutionen

  • Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, EC1M 6BQ, UK.
  • Spirogen, QMB Innovation Centre, 42 New Road, London, E1 2AX, UK.
  • ADC Therapeutics (UK) Ltd, Translation & Innovation Hub Building, Imperial College White City Campus, 84 Wood Lane, London, W12 0BZ, UK.
  • Cancer Research UK Drug-DNA Interactions Research Group, University College London Cancer Institute, 72 Huntley Street, London, WC1E 6BT, UK.
  • Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, EC1M 6BQ, UK. Electronic address: j.f.marshall@qmul.ac.uk.

Förderung

  • Cancer Research UK London Research Institute
  • Pancreatic Cancer Research Fund
  • Medical Research Council

Zitieren

APA

Brown, N. F., Murray, E. R., Cutmore, L. C., Howard, P., Masterson, L., Zammarchi, F., Hartley, J. A., van Berkel, P. H., & Marshall, J. F. (2024). Integrin-αvβ6 targeted peptide-toxin therapy in a novel αvβ6-expressing immunocompetent model of pancreatic cancer. Pancreatology. https://doi.org/10.1016/j.pan.2024.02.013

Vancouver

Brown NF, Murray ER, Cutmore LC, Howard P, Masterson L, Zammarchi F, et al. Integrin-αvβ6 targeted peptide-toxin therapy in a novel αvβ6-expressing immunocompetent model of pancreatic cancer. Pancreatology. 2024. doi:10.1016/j.pan.2024.02.013

BibTeX
@article{Brown2024,
  author = {Brown, Nicholas F and Murray, Elizabeth R and Cutmore, Lauren C and Howard, Philip and Masterson, Luke and Zammarchi, Francesca and Hartley, John A and van Berkel, Patrick H and Marshall, John F},
  title = {Integrin-αvβ6 targeted peptide-toxin therapy in a novel αvβ6-expressing immunocompetent model of pancreatic cancer},
  journal = {Pancreatology},
  year = {2024},
  doi = {10.1016/j.pan.2024.02.013}
}
Kostenlos starten →